ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas (Q42782245)

7 November 2017

title

ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas (English)

1 reference

7 November 2017

1 reference

Ryosuke Sato

1

1 reference

7 November 2017

Hiroshi Watanabe

2

1 reference

7 November 2017

Rieko Genma

3

1 reference

7 November 2017

Masahiro Takeuchi

4

1 reference

7 November 2017

Masato Maekawa

5

1 reference

7 November 2017

Hirotoshi Nakamura

6

1 reference

7 November 2017

publication date

1 December 2010

1 reference

7 November 2017

1 reference

7 November 2017

volume

11

1 reference

7 November 2017

issue

12

1 reference

7 November 2017

page(s)

1743-1750

1 reference

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

K(ATP) channel pharmacogenomics: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Defining a binding pocket for sulfonylureas in ATP-sensitive potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Activating mutations in the ABCC8 gene in neonatal diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.135

21 January 2018

Identifiers

DOI

10.2217/PGS.10.135

1 reference

7 November 2017

1 reference